Federal Register Final rule: FDA is classifying the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation detection systems into Class 2 (special controls). The agency is making available a guidance document entitled Class 2 Special Controls Guidance Document: CFTR Gene Mutation Detection Systems to serve as the special control. To download the guidance, click here. To view this final rule, click here.
